EPE Special Opportunities Limited Stock
Equities
ESO
BMG3163K1053
Investment Management & Fund Operators
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
163.5 GBX | 0.00% | +3.81% | +1.55% |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
Mar. 28 | Earnings Flash (ESO.L) EPE SPECIAL OPPORTUNITIES Reports FY24 Loss GBX-1.33 | MT |
Sales 2023 | -39.36M -48.61M | Sales 2024 | 3.75M 4.63M | Capitalization | 49.3M 60.88M |
---|---|---|---|---|---|
Net income 2023 | -43M -53.11M | Net income 2024 | - 0 | EV / Sales 2023 | -1.34 x |
Net Debt 2023 | 2.48M 3.07M | Net cash position 2024 | 2.02M 2.5M | EV / Sales 2024 | 12.6 x |
P/E ratio 2023 |
-1.2
x | P/E ratio 2024 |
-118
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 40.26% |
1 week | +3.81% | ||
Current month | +10.85% | ||
1 month | +7.21% | ||
3 months | +3.48% | ||
6 months | -5.22% | ||
Current year | +1.55% |
Managers | Title | Age | Since |
---|---|---|---|
Corporate Secretary | 74 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pirouet
BRD | Director/Board Member | 69 | 19-06-30 |
Clive Spears
CHM | Chairman | 70 | - |
Heather Bestwick
BRD | Director/Board Member | - | 17-02-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 163.5 | 0.00% | 0 |
24-04-22 | 163.5 | 0.00% | 0 |
24-04-19 | 163.5 | 0.00% | 2,000 |
24-04-18 | 163.5 | +3.81% | 3,718 |
24-04-17 | 157.5 | 0.00% | 10,000 |
Delayed Quote London S.E., April 23, 2024 at 02:59 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.55% | 60.25M | |
-0.21% | 33.65B | |
+4.67% | 31.27B | |
+6.14% | 5.51B | |
+1.15% | 3.1B | |
+13.31% | 2.93B | |
+20.28% | 2.57B | |
+5.53% | 1.25B | |
-1.50% | 1.05B | |
-0.71% | 840M |
- Stock Market
- Equities
- ESO Stock